Lipid goal attainment in post-acute coronary syndrome patients in China: Results from the 6-month real-world dyslipidemia international study II.

Yanjun GongXuan LiXiang MaHongwei YuYing LiJiyan ChenGuochun ZhangBin WangXiaoyong QiHaiyan MengXiaofeng WangJian-Jun MuXitian HuJingping WangShaowen LiuGang LiuZhenyu YangYu Jie ZhouXiangqing KongYuhu YanChangqian WangJian' An WangLijun WangGuosheng FuLin WeiDaoquan PengShu-Yang ZhangRuogu LiAnhua MaoRui BianWenmin TangYuqin RanJie JiangYong Huo

Published in: Clinical cardiology (2021)

This real-world DYSIS II study in China reports a low LDL-C goal attainment rate in post-ACS patients even after 6 months of LLT. Lack of intensification of statin therapy and underutilization of combinations suggest gaps between real-world treatment practices and guideline recommendations.

Keyphrases

acute coronary syndrome
end stage renal disease
chronic kidney disease
newly diagnosed
ejection fraction
prognostic factors
healthcare
cardiovascular disease
primary care
mesenchymal stem cells
cell therapy